Novo Nordisk A/S (NYSE:NVO) Given Price Target Of $57


As per Novo Nordisk A/S (NYSE:NVO)’s news release on 2016-08-16, its shareholders will get cash dividend of $0.331 per share. The recent press release updated on the record date and payout date, which stands at 2016-08-15 and 2016-08-23, respectively.

The stock will commence trading ex-dividend from 2016-08-11, until, which the shareholders are compelled to keep the holdings so as to qualify for the dividend. Evaluating the dividend distribution mode, it was noted that last year Novo Nordisk A/S (NYSE:NVO) disbursed $0.331 in dividend compared to distribution of $0.331, a year ago.

It highlights a sharp difference in cash payouts of the two years. This shows a major deviation of -12.0834%.

Analyst Perspective

The sell-side market professionals who track the firm’s financial and technical parameters have estimated Novo Nordisk A/S (NYSE:NVO) to attain a price target of $57. It is an average estimate figure given by 1 analysts tracking the stock. The estimates disclosed that the stock can move up on the chart and hit a high of $57. The low price range is set at $57 for next year while the arithmetic mean is seen at 3.

Eyeing Earnings Novo Nordisk A/S (NYSE:NVO) is likely to post quarterly numbers around 2016-11-03 for the quarter ending 2016-09-30. The quarterly EPS projection is set at $0.56 for the period ending on 2016-09-30.

In last quarter ended 2015-12-31, Novo Nordisk A/S (NYSE:NVO) earnings came at $0.6 suggesting a deviation of $0.02. The brokerages targeted EPS of $0.58 for the quarter.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 48 times, 1 visits today)